Saccharomyces Boulardii in Irritable Bowel Syndrome

NCT00589771 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Diarrhea Dominant Irritable Bowel Syndrome

Interventions

DRUG: Saccharomyces boulardii
DRUG: Placebo

Sponsor

Aga Khan University

Collaborators

[object Object]